Crohn's Disease Activity Index

Loading...

%

References

  1. Frank I Scott. AGA Living Clinical Practice Guideline on the Pharmacologic Management of Moderate-to-Severe Crohn's Disease.. Gastroenterology, 2025
  2. Xavier Calvet. Patient-Reported Outcome Measures Poorly Correlate with Objective Inflammatory Bowel Disease Activity Measures: A Systematic Review.. Journal of Crohn's & colitis, 2025
  3. Ashwin N Ananthakrishnan. AGA Clinical Practice Guideline on the Role of Biomarkers for the Management of Crohn's Disease.. Gastroenterology, 2023
  4. Joseph D Feuerstein. AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn's Disease.. Gastroenterology, 2021
  5. Andreas Sturm. ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects.. Journal of Crohn's & colitis, 2019
  6. Ms Heather Catt. PWE-007 A systematic review of outcomes and adverse events for randomised controlled trials in crohn’s disease. Gut, 2018
  7. L. Peyrin-Biroulet. Clinical disease activity, C-reactive protein normalisation and mucosal healing in Crohn's disease in the SONIC trial. Gut, 2013